Hitendra Mahajan

Dr. Hitendra Mahajan


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2021 in Drug Development and Industrial Pharmacy
Verified
Journal Article
Closed access
SDSubhash Deshmane
Subhash Deshmane
PKPrakash Kendre
Prakash Kendre
HMHitendra Mahajan
Hitendra Mahajan
SJShirish Jain
Shirish Jain
Three-dimensional printing (3DP) technology is an innovative tool used in manufacturing medical devices, producing alloys, replacing biological tissues, producing customized dosage forms and so on. Stereolithography (SLA), a 3D printing technique, is very rapid and highly accurate and produces finished products of uniform quality. 3D formulations have been optimized with a perfect tool of artificial intelligence learning techniques. Complex designs/shapes can be fabricated through SLA using the photopolymerization principle. Different 3DP technologies are introduced and the most promising of these, SLA, and its commercial applications, are focused on. The high speed and effectiveness of SLA are highlighted. The working principle of SLA, the materials used and applications of the technique in a wide range of different sectors are highlighted in this review. An innovative idea of 3D printing customized pharmaceutical dosage forms is also presented. SLA compromises several advantages over other methods, such as cost effectiveness, controlled integrity of materials and greater speed. The development of SLA has allowed the development of printed pharmaceutical devices. Considering the present trends, it is expected that SLA will be used along with conventional methods of manufacturing of 3D model. This 3D printing technology may be utilized as a novel tool for delivering drugs on demand. This review will be useful for researchers working on 3D printing technologies.

1 January 2013 in Carbohydrate Polymers
Verified
Journal Article
Closed access
HMHitendra Mahajan
Hitendra Mahajan
VTVinod Kumar Tyagi
Vinod Kumar Tyagi
RPRavindra R. Patil
Ravindra R. Patil
SDSanket B. Dusunge
Sanket B. Dusunge

26 November 2009 in Drug Delivery
Verified
Journal Article
Open access
PDF file
HMHitendra Mahajan
Hitendra Mahajan
SGSurendra Gattani
Surendra Gattani
Intranasal (IN) administration is a promising approach for rapid-onset delivery of medications and to circumvent their first-pass elimination when taken orally. Metoclopramide Hydrochloride (MET HCl) is a potent antiemetic, effective even for preventing emesis induced by cancer chemotherapy. The feasibility of developing an efficacious intranasal formulation of metoclopramide has been undertaken in this study. Formulations were modulated so as to have gelation at physiological ion content after intranasal administration. Gelation was determined by physical appearance. The mucoadhesive force in terms of detachment stress, determined using sheep nasal mucosal membrane, increased with increasing concentration of carbopol. The results of in vitro drug permeation studies across sheep nasal mucosa indicate that effective permeation could be significantly increased by using in situ gelling formulation with carbopol concentration 0.15% or greater. Histological examination did not detect any damage during in vitro permeation studies. Finally, the bioavailability study in rabbits revealed that the absolute bioavailability of MET HCl was significantly increased from 40.67% in the case of the oral drug solution to 54.61% in the case of the nasal in situ gel. This study points to the potential of mucoadhesive nasal in situ gel in terms of ease of administration, accuracy of dosing, prolonged nasal residence and improved drug bioavailability.

15 June 2024 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
RSRahul J. Sarode
Rahul J. Sarode
HMHitendra Mahajan
Hitendra Mahajan

1 January 2009 in Chemical and Pharmaceutical Bulletin
Verified
Journal Article
Open access
PDF file
HMHitendra Mahajan
Hitendra Mahajan
SGSurendra Ganeshlal Gattani
Surendra Ganeshlal Gattani
The purpose of this study was to develop nasal microparticles of metoclopromide employing gellan gum as a polymer by spray drying method. This method of microencapsulation is particularly less dependent on the solubility characteristics of the drug and polymer and is simple, reproducible, and easy to scale up. The microparticles were evaluated for characteristics like particle size, incorporation efficiency, swelling ability, zeta potential, mucoadhesion, thermal analysis, X-ray diffraction (XRD) study and in vitro drug release. The microparticles so prepared had irregular shape and smooth but distorted surface morphology. They were negatively charged. The particle size ranged from 9.38 to 10.67 μm. Differential scanning calorimetry (DSC) studies revealed that metoclopromide was molecularly dispersed inside the microparticles. The swelling was increased with increase in amount of polymer. The release of drug from microparticles was moderately sustained without lag time and attributed to formation of hydrogel; ionically cross linked hydrogel was hypothesized. The formulation was found to be non toxic to nasal tissue. These in vitro preliminary results show that spray dried microparticles based on gellan gum could be suitable nasal delivery system for the administration of metoclopromide.

1 August 2018 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
UDUjwaldip Vijay Deore
Ujwaldip Vijay Deore
HMHitendra Mahajan
Hitendra Mahajan